microRNA information: hsa-miR-190a-5p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-190a-5p | miRbase |
Accession: | MIMAT0000458 | miRbase |
Precursor name: | hsa-mir-190a | miRbase |
Precursor accession: | MI0000486 | miRbase |
Symbol: | NA | HGNC |
RefSeq ID: | NA | GenBank |
Sequence: | UGAUAUGUUUGAUAUAUUAGGU |
Reported expression in cancers: hsa-miR-190a-5p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-190a-5p | liver cancer | upregulation | "Increased expression of miR-190 may cause decrease ......" | 24586785 | |
hsa-miR-190a-5p | pancreatic cancer | upregulation | "Profiling of 95 microRNAs in pancreatic cancer cel ......" | 19030927 | qPCR |
Reported cancer pathway affected by hsa-miR-190a-5p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|
Reported cancer prognosis affected by hsa-miR-190a-5p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-190a-5p | breast cancer | metastasis; cell migration; drug resistance; staging; tumorigenesis; poor survival | "SNPs tagging the 15q22.2 locus showed a significan ......" | 24009311 | |
hsa-miR-190a-5p | breast cancer | drug resistance | "Among these miRNAs we identified-miR-200b-3p miR-1 ......" | 24469723 | |
hsa-miR-190a-5p | prostate cancer | metastasis; poor survival; staging | "MiR-190a belongs to the small noncoding RNA family ......" | 26314494 |
Reported gene related to hsa-miR-190a-5p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-190a-5p | prostate cancer | AR | "Reduced expression of miR-190a was inversely corre ......" | 26314494 |
hsa-miR-190a-5p | breast cancer | ESR1 | "In addition the promoter region of miR-190a was de ......" | 24009311 |
hsa-miR-190a-5p | gastric cancer | FOXP2 | "To investigate how microRNA-190 miR-190 regulates ......" | 27382302 |
hsa-miR-190a-5p | prostate cancer | YBX1 | "Taken together our findings identified a biochemic ......" | 26314494 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-190a-5p | BACH2 | 9 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LGG; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.252; TCGA COAD -0.382; TCGA ESCA -0.326; TCGA KIRC -0.177; TCGA KIRP -0.196; TCGA LGG -0.101; TCGA THCA -0.243; TCGA STAD -0.414; TCGA UCEC -0.307 |
hsa-miR-190a-5p | IL1RAP | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LUSC; PRAD; THCA | MirTarget | TCGA BLCA -0.193; TCGA CESC -0.144; TCGA ESCA -0.389; TCGA HNSC -0.103; TCGA KIRC -0.265; TCGA KIRP -0.322; TCGA LUSC -0.202; TCGA PRAD -0.091; TCGA THCA -0.598 |
hsa-miR-190a-5p | ACTG1 | 9 cancers: BLCA; BRCA; KIRC; KIRP; LIHC; LUAD; LUSC; THCA; UCEC | MirTarget | TCGA BLCA -0.072; TCGA BRCA -0.086; TCGA KIRC -0.098; TCGA KIRP -0.069; TCGA LIHC -0.065; TCGA LUAD -0.105; TCGA LUSC -0.089; TCGA THCA -0.103; TCGA UCEC -0.093 |
hsa-miR-190a-5p | F2R | 9 cancers: BLCA; BRCA; COAD; LGG; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.154; TCGA BRCA -0.09; TCGA COAD -0.233; TCGA LGG -0.209; TCGA PAAD -0.227; TCGA PRAD -0.12; TCGA THCA -0.103; TCGA STAD -0.119; TCGA UCEC -0.179 |
hsa-miR-190a-5p | SEC23A | 9 cancers: BLCA; ESCA; KIRC; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.151; TCGA ESCA -0.081; TCGA KIRC -0.094; TCGA LUSC -0.103; TCGA PRAD -0.122; TCGA SARC -0.122; TCGA THCA -0.184; TCGA STAD -0.172; TCGA UCEC -0.099 |
hsa-miR-190a-5p | DRP2 | 11 cancers: BRCA; CESC; ESCA; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.18; TCGA CESC -0.213; TCGA ESCA -0.403; TCGA LGG -0.237; TCGA LUAD -0.257; TCGA LUSC -0.423; TCGA PAAD -0.316; TCGA PRAD -0.13; TCGA SARC -0.219; TCGA STAD -0.753; TCGA UCEC -0.257 |
hsa-miR-190a-5p | ASAP1 | 9 cancers: COAD; ESCA; HNSC; KIRC; KIRP; PAAD; PRAD; THCA; STAD | MirTarget | TCGA COAD -0.155; TCGA ESCA -0.153; TCGA HNSC -0.06; TCGA KIRC -0.146; TCGA KIRP -0.138; TCGA PAAD -0.116; TCGA PRAD -0.084; TCGA THCA -0.083; TCGA STAD -0.213 |
hsa-miR-190a-5p | PFDN4 | 9 cancers: ESCA; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; THCA; STAD | MirTarget | TCGA ESCA -0.076; TCGA KIRC -0.138; TCGA KIRP -0.106; TCGA LGG -0.051; TCGA LIHC -0.118; TCGA LUSC -0.128; TCGA PRAD -0.072; TCGA THCA -0.097; TCGA STAD -0.101 |
Enriched cancer pathways of putative targets